about
Review: [corrected] The changing face of the HIV epidemic in sub-Saharan AfricaA Modified P1 Moiety Enhances in vitro Antiviral Activity against Various Multi-Drug-Resistant HIV-1 Variants and in vitro CNS Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413HIV Infection in the Elderly: Arising ChallengesA Novel Point-of-Care BioNanoSensor for Rapid HIV Detection and Treatment MonitoringA missing piece in the puzzle: HIV in mature adults in sub-Saharan AfricaInpatient health services utilization among HIV-infected adult patients in care 2002-2007.Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia.Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up.Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.The new invincibles: HIV screening among older adults in the U.S.Older HIV-infected individuals present late and have a higher mortality: Brighton, UK cohort study.Decreased chronic morbidity but elevated HIV associated cytokine levels in HIV-infected older adults receiving HIV treatment: benefit of enhanced access to care?HIV infection in the elderlyDisparities in antiretroviral treatment: a comparison of behaviorally HIV-infected youth and adults in the HIV Research NetworkPneumonia and influenza hospitalization in HIV-positive seniorsA novel tricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor, GRL-0739, effectively inhibits the replication of multidrug-resistant HIV-1 variants and has a desirable central nervous system penetration property in vitro.Sexual risk taking and club drug use across three age cohorts of HIV-positive gay and bisexual men in New York City.CD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy.A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitro.[Sexually transmitted diseases among the elderly: a systematic review].Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levelsCost-effectiveness of HIV screening in patients older than 55 years of age.[Descriptive aspects of HIV/AIDS in patients aged 50 years and over followed at the Treatment Center of Bafoussam - Cameroon].Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected WomenFactors associated with presenting late or with advanced HIV disease in the Netherlands, 1996-2014: results from a national observational cohortContemporary costs of HIV healthcare in the HAART eraImmunological and Clinical Responses following the Use of Antiretroviral Therapy among Elderly HIV-Infected Individuals Attending Care and Treatment Clinic in Northwestern Tanzania: A Retrospective Cohort StudyGRL-0519, a novel oxatricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor (PI), potently suppresses replication of a wide spectrum of multi-PI-resistant HIV-1 variants in vitro.HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD).Substance abuse treatment in human immunodeficiency virus: the role of patient-provider discussions.Determinants of Mortality among HIV Positives after Initiating Antiretroviral Therapy in Western Ethiopia: A Hospital-Based Retrospective Cohort StudyCorrelates of Combination Antiretroviral Adherence Among Recently Diagnosed Older HIV-Infected Adults Between 50 and 64 yearsUse of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.Cost of noninfectious comorbidities in patients with HIV.Epidemiology of HIV and response to antiretroviral therapy in the middle aged and elderly.Older Adults with HIV/AIDS in Rural China.Late HIV diagnosis: Differences by rural/urban residence, Florida, 2007-2011.Prevention of HIV among older adults: a literature review and recommendations for future research.Frequency and correlates of late presentation for HIV infection in France: older adults are a risk group - results from the ANRS-VESPA2 Study, France.
P2860
Q27022927-56DAAF69-A750-4A72-9C82-A04E4B13C934Q27728053-03B8A47C-FC33-410A-B500-D66948FB0521Q28076000-C0FC6AD3-7042-46C6-BFEA-205E287F67F5Q30401403-C164ADAA-DF24-42A2-9CC9-9FAB15880224Q33353214-8AE42419-2488-43A2-BD7B-535A6ACCC0A0Q33699011-3F51F36C-EA0B-42B4-8BEB-6A3F470FE8D4Q33719226-FD1A834B-3D48-4A74-8CC6-A7475A365B5DQ33783987-538A52E2-575F-4AF9-BE7C-22EDAFA1BA7AQ33859987-CECC1EED-8163-4453-8448-8696DC2D52B9Q33958103-617E520F-9E84-4C60-A5D4-E252627B3738Q34405393-C4E598FF-0E79-4CA3-8651-AA92BDF8D6BDQ34691316-613701B4-F8BA-4049-926D-FBB34A8582E2Q35021733-7D0A29FA-4134-4837-A29B-B880CD319711Q35086332-54C6D3AE-3F01-4DEB-822D-DF24FBDCA9BDQ35175506-FB202E09-D805-4C6F-93EC-84CEAE1964E4Q35383359-C8840D50-818A-4C1B-86A6-A48431FCB33DQ35386013-C5D20F30-5394-4EC4-90E3-1750B4910314Q35492079-F07BEA7E-10A6-4A1D-9FCF-ACAE80F95145Q35800805-49698832-BF9D-4844-9094-B572FDD0041FQ35840811-553B6175-1F0E-4D59-9975-7A9886F37F2EQ35874903-32FB109E-731D-4E28-8161-83878C04A2D2Q36144187-B541FFF4-8FF9-4AF6-A990-1733786FA030Q36191220-B36E39FE-9257-4259-85C5-2F376E7B2FD0Q36372447-FB961A38-F3F7-4017-BEB0-2FA8DA394F48Q36462052-B1C951E0-E1F7-4C4F-B97B-7E5041320C80Q36471926-B081EC1D-5ABF-4D0A-B1F5-FCE6D77A2F17Q36550975-761B5F6D-1047-4DEA-BF8D-07D4C268BF85Q36693723-50AF1276-E880-4565-A2CC-876AAECED721Q36785919-4742200B-178A-411A-8BBB-184C415722CDQ36946140-D0FCFF44-F223-42B6-B997-71B8B7100662Q36952590-FC444085-B4D1-43C7-A5D6-FD9C38F4F3CAQ37156626-7ED7B2D1-CE72-4727-AAD2-FD312817CD10Q37184269-2EC18F30-6121-46AE-94E9-243E8D99BDF7Q37208045-44ACE03F-7883-401C-B075-9D52B788E353Q37213494-23DC2CB9-4785-40A6-B4D9-09374A4D7CDCQ37419826-2D0663E5-C993-4ABB-BE11-822C4DDD48F1Q37486356-41CA85BB-D225-45F1-9BC1-AAE31F08C015Q37701098-032BE966-A5EB-45A0-9BB6-5ED1C62FD729Q38049989-336E6043-96EA-42A6-B6A5-4B734CB7E03DQ38421157-4470B934-524D-47B8-AC03-A141B01D61E6
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
HIV infection in older patients in the HAART era.
@ast
HIV infection in older patients in the HAART era.
@en
type
label
HIV infection in older patients in the HAART era.
@ast
HIV infection in older patients in the HAART era.
@en
prefLabel
HIV infection in older patients in the HAART era.
@ast
HIV infection in older patients in the HAART era.
@en
P356
P1476
HIV infection in older patients in the HAART era.
@en
P2093
Laurence Weiss
Sophie Grabar
P356
10.1093/JAC/DKI411
P407
P577
2005-11-11T00:00:00Z